Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness
Antibiotics · 15.08.2026 · 15 (8) · 790
DOI: 10.3390/antibiotics15080790 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 15.08.2026. Verfasst von Katarzyna Kuszewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Laboratory, St. Alexander Hospital, 25-316 Kielce, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbapenem-resistant Enterobacterales (CRE) represent one of the most important antimicrobial resistance threats in Europe, particularly in healthcare settings. Their increasing epidemiological significance is driven by the dissemination of carbapenem-resistant Klebsiella pneumoniae, the emergence of high-risk clones, horizontal transfer of mobile genetic elements, and the convergence of antimicrobial resistance and hypervirulence. Despite the growing epidemiological importance of CRE, surveillance and preparedness remain heterogeneous across European countries, creating a need for a continent-wide assessment of existing surveillance systems, implementation gaps, and emerging challenges. This narrative review summarizes the current epidemiology of CRE in Europe and critically discusses the role of European and global surveillance systems in monitoring their spread. Particular attention is given to the European Antimicrobial Resistance Surveillance Network (EARS-Net), European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net), Healthcare-Associated Infections Surveillance Network (HAI-Net), European Surveillance of Antimicrobial Consumption Network (ESAC-Net), Point Prevalence Survey (PPS), EpiPulse/TESSy, the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) programme, and the World Health Organization Global Antimicrobial Resistance and Use Surveillance System (WHO GLASS). Although Europe has well-established surveillance infrastructures, substantial heterogeneity persists among countries with respect to microbiological and genomic diagnostic capacity, reporting practices, infection prevention and control (IPC), antimicrobial stewardship, healthcare infrastructure, and implementation of national policies. These differences limit data comparability and may delay the detection of colonization, outbreaks, and cross-border transmission. The available evidence indicates that effective CRE control requires integrated surveillance combining microbiological, genomic, epidemiological, and antimicrobial consumption data within a coordinated One Health framework. Further expansion of genomic surveillance, harmonization of surveillance indicators, strengthening of healthcare system preparedness, and wider implementation of antimicrobial stewardship programmes are identified as priority areas for improve CRE prevention and control across Europe. By integrating evidence across surveillance, diagnostics, infection prevention and control, and antimicrobial stewardship, this review highlights key gaps in current European approaches and provides a framework for prioritizing future surveillance and preparedness efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diagnostic Laboratory, St. Alexander Hospital, 25-316 Kielce, Poland.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, Poland.
- Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland.
ORCID-Profile: Katarzyna Kuszewska, Karolina Klesiewicz, Paulina Leśniak, Agnieszka Chmielarczyk
Zitieren
APA
Kuszewska, K., Klesiewicz, K., Leśniak, P., & Chmielarczyk, A. (2026). Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness. Antibiotics, 15(8), 790. https://doi.org/10.3390/antibiotics15080790
Vancouver
Kuszewska K, Klesiewicz K, Leśniak P, Chmielarczyk A. Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness. Antibiotics. 2026;15(8):790. doi:10.3390/antibiotics15080790
BibTeX
@article{Kuszewska2026,
author = {Kuszewska, Katarzyna and Klesiewicz, Karolina and Leśniak, Paulina and Chmielarczyk, Agnieszka},
title = {Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {8},
pages = {790},
doi = {10.3390/antibiotics15080790}
}
EUVIMED